{
  "id": "muscular-dystrophy-adult",
  "title": "Muscular Dystrophy (Adult)",
  "version": "1.2",
  "icd10": [
    "** G71.0 (Muscular dystrophy)",
    "G71.01 (Duchenne or Becker muscular dystrophy)",
    "G71.02 (Facioscapulohumeral muscular dystrophy)",
    "G71.09 (Other specified muscular dystrophies)"
  ],
  "scope": "** Evaluation and management of muscular dystrophies presenting in adults or diagnosed in adulthood. Covers FSHD, LGMD subtypes, Becker MD, OPMD, Emery-Dreifuss MD, and distal myopathies. Includes diagnostic workup (genetic testing, muscle biopsy), cardiac and respiratory monitoring, symptomatic management, and emerging gene therapies. Excludes myotonic dystrophy (covered separately) and pediatric-onset Duchenne MD (though includes adult Becker MD).",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Core Labs (All Patients)": [
        {
          "item": "CK (total creatine kinase) (CPT 82550)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Elevated in muscular dystrophies; degree varies by subtype (very high in BMD/LGMD, mildly elevated in FSHD/OPMD)",
          "target": "Normal (30-200 U/L); elevated supports myopathy"
        },
        {
          "item": "CMP (CPT 80053)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Renal function (rhabdomyolysis risk); electrolytes; LFTs (may be elevated from muscle source, not hepatic)",
          "target": "Normal; note ALT/AST may be elevated from muscle"
        },
        {
          "item": "CBC (CPT 85025)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Baseline",
          "target": "Normal"
        },
        {
          "item": "TSH (CPT 84443)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Thyroid myopathy in differential",
          "target": "Normal"
        },
        {
          "item": "Aldolase",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Elevated in inflammatory and dystrophic myopathies; may be more sensitive than CK in some dystrophies",
          "target": "Normal"
        }
      ],
      "Extended Labs": [
        {
          "item": "Genetic testing panel (muscular dystrophy panel) (CPT 81400-81408)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Definitive diagnosis; >30 LGMD genes; dystrophin gene for BMD; D4Z4 for FSHD; PABPN1 for OPMD",
          "target": "No pathogenic variant (positive = specific diagnosis)"
        },
        {
          "item": "Dystrophin gene analysis (deletion/duplication ± sequencing)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Becker MD diagnosis; large deletions (60-70%) detected by MLPA; sequencing for point mutations",
          "target": "No deletion/duplication; no pathogenic variant"
        },
        {
          "item": "D4Z4 repeat sizing (FSHD1)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "FSHD1: contraction of D4Z4 repeats on chromosome 4q35 (1-10 repeats on permissive 4qA allele)",
          "target": "Normal (>10 repeats); reduced = FSHD1"
        },
        {
          "item": "SMCHD1 gene testing",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "FSHD2: SMCHD1 mutations with D4Z4 hypomethylation on permissive allele",
          "target": "No pathogenic variant"
        },
        {
          "item": "PABPN1 GCN repeat",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "OPMD: GCN expansion (>8 repeats vs normal 6)",
          "target": "Normal (6 repeats); expanded = OPMD"
        },
        {
          "item": "EMN/LMNA gene testing",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Emery-Dreifuss: emerin (X-linked) or lamin A/C (AD/AR) mutations; cardiac risk stratification",
          "target": "No pathogenic variant"
        },
        {
          "item": "Myositis antibody panel (if inflammatory myopathy in differential)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Differentiate inflammatory from dystrophic myopathy; includes Jo-1, Mi-2, SRP, HMGCR",
          "target": "Negative"
        },
        {
          "item": "Troponin",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "rationale": "Cardiac involvement assessment; may be chronically mildly elevated in dystrophies",
          "target": "Normal (<0.04 ng/mL); chronically elevated in some dystrophies"
        },
        {
          "item": "BNP/NT-proBNP",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Heart failure screening; cardiomyopathy",
          "target": "Normal"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "Muscle biopsy with immunohistochemistry",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "When genetic testing is inconclusive; dystrophin staining (BMD: reduced), sarcoglycan panel (LGMD), merosin (LGMD R23)",
          "target": "Normal staining; reduced/absent specific protein directs genetic testing"
        },
        {
          "item": "Whole exome/genome sequencing",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Undiagnosed muscular dystrophy after targeted gene panels; novel gene discovery",
          "target": "No known pathogenic variant"
        },
        {
          "item": "MRI of muscles (thigh/calf) (CPT 73721)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Pattern of fatty infiltration helps differentiate MD subtypes; guides biopsy site",
          "target": "Normal muscle without fatty infiltration"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential Studies": [
        {
          "item": "NCS/EMG (CPT 95907-95913, 95860-95870)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Characterize myopathic vs neurogenic pattern; guides further workup",
          "target": "Myopathic pattern: short-duration, low-amplitude, polyphasic MUPs; early recruitment; no spontaneous activity (or minimal)",
          "contraindications": "None"
        },
        {
          "item": "Echocardiogram (CPT 93306)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "timing": "ALL patients with muscular dystrophy; cardiomyopathy screening (especially BMD, EDMD, LGMD)",
          "target": "Normal LV function (EF >55%); no wall motion abnormalities; no dilation",
          "contraindications": "None"
        },
        {
          "item": "Pulmonary function tests (FVC, FEV1, MIP, MEP) (CPT 94010)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Respiratory muscle involvement; restrictive pattern; guide ventilation decisions",
          "target": "FVC >80% predicted; MIP more negative than -60 cmH2O",
          "contraindications": "None"
        },
        {
          "item": "12-lead ECG (CPT 93000)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "timing": "Conduction abnormalities; arrhythmia; EDMD and LMNA carriers at high risk of sudden cardiac death",
          "target": "Normal sinus rhythm; normal PR, QRS, QTc intervals",
          "contraindications": "None"
        }
      ],
      "Extended Studies": [
        {
          "item": "Cardiac MRI",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Gold standard for detecting myocardial fibrosis (late gadolinium enhancement); more sensitive than echo for early cardiomyopathy",
          "target": "No late gadolinium enhancement; normal EF; no fibrosis",
          "contraindications": "MRI-incompatible devices; severe renal failure (gadolinium)"
        },
        {
          "item": "Holter monitor (24-48 hr)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Arrhythmia detection; EDMD and LMNA carriers especially; AV block, atrial fibrillation",
          "target": "Normal rhythm; no high-grade conduction disease",
          "contraindications": "None"
        },
        {
          "item": "Overnight oximetry or sleep study (polysomnography)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Nocturnal hypoventilation; sleep-disordered breathing; guide NIV initiation",
          "target": "Normal overnight O2 saturation (>95%); no significant desaturations",
          "contraindications": "None"
        },
        {
          "item": "MRI of muscles (thigh, calf, shoulder)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Subtype differentiation by pattern of fatty infiltration; FSHD: periscapular + hamstring; LGMD variable",
          "target": "No fatty infiltration; specific patterns guide diagnosis",
          "contraindications": "MRI-incompatible devices"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "Modified barium swallow",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "OPMD: dysphagia quantification; aspiration risk assessment",
          "target": "Normal swallow; no aspiration or penetration",
          "contraindications": "None"
        },
        {
          "item": "Video fluoroscopic swallow study",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "OPMD: pharyngeal dysfunction characterization; surgical planning (cricopharyngeal myotomy)",
          "target": "Normal pharyngeal contraction",
          "contraindications": "None"
        },
        {
          "item": "Bone density (DEXA)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Osteoporosis from reduced weight-bearing and if on corticosteroids",
          "target": "Normal T-score (>-1.0)",
          "contraindications": "None"
        }
      ]
    },
    "Treatment": {
      "Acute/Emergent": [
        {
          "item": "BiPAP/NIV (non-invasive ventilation)",
          "route": "NIV",
          "indication": "Acute respiratory failure from respiratory muscle weakness; FVC <50% or acute decompensation",
          "dosing": {
            "doseOptions": [
              {
                "text": "IPAP 10-16 cmH2O",
                "orderSentence": "BiPAP/NIV (non-invasive ventilation) IPAP 10-16 cmH2O NIV"
              }
            ],
            "route": "NIV",
            "instructions": "IPAP 10-16 cmH2O, EPAP 4-6 cmH2O; titrate to comfort and SpO2 >92%; may need 24-hr support in acute setting",
            "orderSentence": "BiPAP/NIV (non-invasive ventilation) IPAP 10-16 cmH2O NIV"
          },
          "contraindications": "Inability to protect airway; facial trauma preventing mask seal; pneumothorax",
          "monitoring": "SpO2; ABG; respiratory rate; patient comfort; CO2 levels; mask fit",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "IV Normal Saline",
          "route": "IV",
          "indication": "Rhabdomyolysis prevention/treatment if CK markedly elevated (>5x ULN) or acute renal injury",
          "dosing": {
            "doseOptions": [
              {
                "text": "1000 mL",
                "orderSentence": "IV Normal Saline 1000 mL IV"
              }
            ],
            "route": "IV",
            "instructions": "1-2 L NS bolus; target urine output >200 mL/hr if rhabdomyolysis; alkalinize urine if CK >10,000",
            "orderSentence": "IV Normal Saline 1000 mL IV"
          },
          "contraindications": "Heart failure; volume overload",
          "monitoring": "CK; renal function; urine output; myoglobinuria",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        }
      ],
      "Cardiac Management": [
        {
          "item": "Lisinopril",
          "route": "PO",
          "indication": "Cardiomyopathy prevention/treatment; ACE inhibitor for LV dysfunction in BMD, LGMD, EDMD",
          "dosing": {
            "doseOptions": [
              {
                "text": "2.5 mg",
                "orderSentence": "Lisinopril 2.5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 2.5-5 mg daily; titrate to 10-20 mg daily; initiate at first sign of LV dysfunction or prophylactically in high-risk dystrophies (BMD)",
            "orderSentence": "Lisinopril 2.5 mg PO"
          },
          "contraindications": "Bilateral renal artery stenosis; pregnancy; angioedema history; hyperkalemia",
          "monitoring": "BP; K+; renal function; cough; EF on echo",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Carvedilol",
          "route": "PO",
          "indication": "Heart failure from cardiomyopathy; beta-blocker for LV dysfunction",
          "dosing": {
            "doseOptions": [
              {
                "text": "3.125 mg",
                "orderSentence": "Carvedilol 3.125 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 3.125 mg BID; double dose q2wk as tolerated; max 25 mg BID; take with food",
            "orderSentence": "Carvedilol 3.125 mg PO"
          },
          "contraindications": "Severe bradycardia; 2nd/3rd degree AV block; decompensated HF; severe asthma",
          "monitoring": "HR; BP; fatigue; fluid retention; EF",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Implantable cardioverter-defibrillator (ICD) / Pacemaker",
          "route": "Device",
          "indication": "EDMD and LMNA mutations: prophylactic ICD/pacemaker for conduction defects; high risk of sudden cardiac death even with normal EF",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Implantable cardioverter-defibrillator (ICD) / Pacemaker N/A Device"
              }
            ],
            "route": "Device",
            "instructions": "LMNA mutation carriers: prophylactic ICD/pacemaker per HRS guidelines; do NOT wait for symptomatic bradycardia; BMD cardiomyopathy: ICD per standard heart failure criteria",
            "orderSentence": "Implantable cardioverter-defibrillator (ICD) / Pacemaker N/A Device"
          },
          "contraindications": "Specific to device implantation",
          "monitoring": "Device checks q6-12 months; rhythm monitoring; lead integrity",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        }
      ],
      "Symptomatic and Supportive": [
        {
          "item": "Nocturnal BiPAP",
          "route": "NIV",
          "indication": "Nocturnal hypoventilation; FVC <50% predicted or symptomatic nocturnal hypoxemia",
          "dosing": {
            "doseOptions": [
              {
                "text": "IPAP 12-18 cmH2O",
                "orderSentence": "Nocturnal BiPAP IPAP 12-18 cmH2O NIV"
              }
            ],
            "route": "NIV",
            "instructions": "IPAP 12-18, EPAP 4-6 cmH2O; titrate per polysomnography; start when FVC <50% or earlier if symptomatic; assess compliance",
            "orderSentence": "Nocturnal BiPAP IPAP 12-18 cmH2O NIV"
          },
          "contraindications": "Inability to use mask; untreated pneumothorax",
          "monitoring": "Overnight oximetry; ABG or cap gas q6-12mo; mask comfort and compliance",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Gabapentin",
          "route": "PO",
          "indication": "Pain from musculoskeletal sources; contractures; neuropathic component",
          "dosing": {
            "doseOptions": [
              {
                "text": "300 mg",
                "orderSentence": "Gabapentin 300 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 300 mg qHS; titrate by 300 mg q1-3d; target 300-600 mg TID; max 3600 mg/day",
            "orderSentence": "Gabapentin 300 mg PO"
          },
          "contraindications": "Severe renal impairment (dose adjust)",
          "monitoring": "Sedation; dizziness; respiratory depression (caution in respiratory compromise)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Acetaminophen",
          "route": "PO",
          "indication": "Musculoskeletal pain; contracture-related pain",
          "dosing": {
            "doseOptions": [
              {
                "text": "500 mg",
                "orderSentence": "Acetaminophen 500 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "500-1000 mg q6h as needed; max 3000 mg/day (2000 mg/day in elderly or hepatic impairment)",
            "orderSentence": "Acetaminophen 500 mg PO"
          },
          "contraindications": "Severe hepatic impairment",
          "monitoring": "Hepatic function; total daily dose",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Baclofen",
          "route": "PO",
          "indication": "Spasticity; muscle stiffness from contractures",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg",
                "orderSentence": "Baclofen 5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg TID; increase by 5 mg/dose q3d; max 80 mg/day divided TID-QID; taper to discontinue (do NOT stop abruptly)",
            "orderSentence": "Baclofen 5 mg PO"
          },
          "contraindications": "Abrupt withdrawal (seizures, hallucinations); severe renal impairment",
          "monitoring": "Sedation; weakness (may unmask underlying weakness); respiratory depression",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Tizanidine",
          "route": "PO",
          "indication": "Spasticity (alternative to baclofen); muscle spasms",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 mg",
                "orderSentence": "Tizanidine 2 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 2 mg qHS; may increase by 2-4 mg q6-8h; max 36 mg/day",
            "orderSentence": "Tizanidine 2 mg PO"
          },
          "contraindications": "Concurrent CYP1A2 inhibitors (ciprofloxacin, fluvoxamine); hepatic impairment",
          "monitoring": "LFTs at baseline, 1 month, 3 months; sedation; hypotension; dry mouth",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Modafinil",
          "route": "PO",
          "indication": "Fatigue; excessive daytime sleepiness",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg",
                "orderSentence": "Modafinil 100 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 100 mg every morning; may increase to 200 mg daily; avoid afternoon dosing",
            "orderSentence": "Modafinil 100 mg PO"
          },
          "contraindications": "Hypersensitivity; cardiac arrhythmia; left ventricular hypertrophy",
          "monitoring": "Headache; insomnia; cardiac monitoring if history; BP",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Sertraline",
          "route": "PO",
          "indication": "Depression; anxiety related to chronic progressive disease (ALTERNATIVE to duloxetine — do NOT combine; serotonin syndrome risk)",
          "dosing": {
            "doseOptions": [
              {
                "text": "25 mg",
                "orderSentence": "Sertraline 25 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 25 mg daily; increase by 25-50 mg q1-2 weeks; max 200 mg/day",
            "orderSentence": "Sertraline 25 mg PO"
          },
          "contraindications": "Concurrent MAOIs; concurrent duloxetine (serotonin syndrome); caution with QT-prolonging drugs",
          "monitoring": "Suicidality (first weeks); GI upset; sexual dysfunction; hyponatremia; serotonin syndrome if combined with other serotonergic agents",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Duloxetine",
          "route": "PO",
          "indication": "Depression with comorbid pain; neuropathic pain component (ALTERNATIVE to sertraline — do NOT combine; serotonin syndrome risk)",
          "dosing": {
            "doseOptions": [
              {
                "text": "30 mg",
                "orderSentence": "Duloxetine 30 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 30 mg daily x 1-2 weeks; increase to 60 mg daily; max 120 mg/day",
            "orderSentence": "Duloxetine 30 mg PO"
          },
          "contraindications": "Severe hepatic impairment; concurrent MAOIs; concurrent sertraline (serotonin syndrome); uncontrolled narrow-angle glaucoma",
          "monitoring": "LFTs; BP; nausea (take with food); serotonin syndrome if combined with other serotonergic agents",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Oxybutynin",
          "route": "PO",
          "indication": "Urinary urgency and frequency from neurogenic bladder dysfunction",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg",
                "orderSentence": "Oxybutynin 5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg BID-TID; max 5 mg QID; extended-release 5-30 mg daily preferred",
            "orderSentence": "Oxybutynin 5 mg PO"
          },
          "contraindications": "Uncontrolled narrow-angle glaucoma; urinary retention; GI obstruction",
          "monitoring": "Dry mouth; cognitive effects (especially elderly); constipation; urinary retention",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Mirabegron",
          "route": "PO",
          "indication": "Overactive bladder (alternative to anticholinergics; fewer cognitive effects)",
          "dosing": {
            "doseOptions": [
              {
                "text": "25 mg",
                "orderSentence": "Mirabegron 25 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 25 mg daily; may increase to 50 mg daily",
            "orderSentence": "Mirabegron 25 mg PO"
          },
          "contraindications": "Severe uncontrolled hypertension",
          "monitoring": "BP; urinary retention; hepatic function",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Cyclobenzaprine",
          "route": "PO",
          "indication": "Muscle spasms; musculoskeletal pain",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg",
                "orderSentence": "Cyclobenzaprine 5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg TID; max 10 mg TID; short-term use (2-3 weeks); avoid in elderly",
            "orderSentence": "Cyclobenzaprine 5 mg PO"
          },
          "contraindications": "Concurrent MAOIs; recent MI; arrhythmia; heart failure; hyperthyroidism",
          "monitoring": "Sedation; dry mouth; dizziness; anticholinergic effects",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Melatonin",
          "route": "PO",
          "indication": "Insomnia; sleep disturbance common in chronic neuromuscular disease",
          "dosing": {
            "doseOptions": [
              {
                "text": "3 mg",
                "orderSentence": "Melatonin 3 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "3-5 mg PO 30-60 min before bedtime; max 10 mg",
            "orderSentence": "Melatonin 3 mg PO"
          },
          "contraindications": "None significant",
          "monitoring": "Daytime drowsiness; vivid dreams",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Disease-Specific Therapies": [
        {
          "item": "Deflazacort",
          "route": "PO",
          "indication": "Corticosteroid for ambulatory Duchenne/Becker patients (limited evidence for adult BMD specifically); slows loss of ambulation",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.9 mg/kg",
                "orderSentence": "Deflazacort 0.9 mg/kg PO"
              }
            ],
            "route": "PO",
            "instructions": "0.9 mg/kg/day; evidence strongest in Duchenne; limited data in adult BMD but may be considered; take with food",
            "orderSentence": "Deflazacort 0.9 mg/kg PO"
          },
          "pretreatment": "Bone density; BP; glucose; vaccination status",
          "contraindications": "Active infection; uncontrolled diabetes; systemic fungal infection",
          "monitoring": "Weight; bone density; blood glucose; BP; cataracts; adrenal function",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Prednisone (alternate-day)",
          "route": "PO",
          "indication": "Alternative corticosteroid for dystrophinopathies when deflazacort unavailable; slows decline in muscle function",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.75 mg/kg",
                "orderSentence": "Prednisone (alternate-day) 0.75 mg/kg PO"
              }
            ],
            "route": "PO",
            "instructions": "0.75 mg/kg every other day; alternate-day dosing reduces side effects; taper if discontinuing",
            "orderSentence": "Prednisone (alternate-day) 0.75 mg/kg PO"
          },
          "pretreatment": "Bone density; BP; glucose; vaccination status",
          "contraindications": "Active infection; uncontrolled diabetes; GI ulceration",
          "monitoring": "Weight; bone density; blood glucose; BP; cataracts; adrenal function",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Cricopharyngeal myotomy (surgical)",
          "route": "Surgical",
          "indication": "OPMD with disabling dysphagia; cricopharyngeal muscle dysfunction causing obstruction",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Cricopharyngeal myotomy (surgical) N/A Surgical"
              }
            ],
            "route": "Surgical",
            "instructions": "Surgical section of cricopharyngeal muscle; performed by ENT/head-neck surgeon; improves swallowing in 80-90% of OPMD patients",
            "orderSentence": "Cricopharyngeal myotomy (surgical) N/A Surgical"
          },
          "pretreatment": "Swallowing study confirming cricopharyngeal dysfunction; anesthesia risk assessment",
          "contraindications": "Active aspiration pneumonia; poor surgical candidate; severe respiratory compromise",
          "monitoring": "Swallowing assessment post-procedure; aspiration monitoring; wound healing",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Scapular fixation surgery",
          "route": "Surgical",
          "indication": "FSHD with severe scapular winging limiting arm elevation; failure of conservative management",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Scapular fixation surgery N/A Surgical"
              }
            ],
            "route": "Surgical",
            "instructions": "Scapulothoracic fusion or scapulopexy; improves overhead arm function in selected FSHD patients; requires adequate deltoid strength",
            "orderSentence": "Scapular fixation surgery N/A Surgical"
          },
          "pretreatment": "Adequate deltoid function confirmed; respiratory risk assessment; orthopedic evaluation",
          "contraindications": "Poor surgical candidate; inadequate deltoid function; severe respiratory compromise",
          "monitoring": "Post-operative ROM; shoulder function assessment; wound healing",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Gene therapy (clinical trials)",
          "route": "Variable",
          "indication": "Emerging therapies for specific dystrophy subtypes (LGMD R9/FKRP, LGMD R2/dysferlin, FSHD); currently investigational",
          "dosing": {
            "doseOptions": [
              {
                "text": "Per protocol",
                "orderSentence": "Gene therapy (clinical trials) Per protocol Variable"
              }
            ],
            "route": "Variable",
            "instructions": "Refer eligible patients to registries (clinicaltrials.gov); AAV-based gene replacement for sarcoglycanopathies and dysferlinopathies under investigation",
            "orderSentence": "Gene therapy (clinical trials) Per protocol Variable"
          },
          "pretreatment": "Genetic diagnosis confirmed; trial eligibility screening; informed consent",
          "contraindications": "Per specific trial protocol",
          "monitoring": "Trial-specific adverse events; immune response to AAV vector",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Neuromuscular specialist for diagnostic confirmation, genetic testing interpretation, and long-term management",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Cardiology for echocardiogram, Holter, cardiac MRI, and cardiomyopathy management; electrophysiology referral for EDMD/LMNA carriers",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Pulmonology for PFT interpretation, NIV initiation and titration, and respiratory failure management",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Respiratory therapy for BiPAP setup and titration, cough assist training, and secretion management",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Genetic counseling for inheritance pattern discussion, family screening, and reproductive planning",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Physical therapy for stretching, contracture prevention, submaximal strengthening, and mobility optimization",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Occupational therapy for ADL adaptation, upper extremity function, and assistive technology evaluation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Speech therapy for OPMD dysphagia assessment, swallowing strategies, and communication support",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Nutrition/Dietitian for caloric needs assessment, weight management, and dietary modification for dysphagia",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Orthopedic surgery for scoliosis management, contracture release, and scapular fixation (FSHD)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Social work for disability services, insurance navigation, MDA resources, and caregiver support",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Palliative care for goals of care discussion and advance care planning in progressive disease",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        }
      ],
      "Patient Instructions": [
        {
          "item": "Carry a medical alert card or bracelet stating muscular dystrophy diagnosis and AVOID SUCCINYLCHOLINE for all anesthesia encounters",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "Return to ED immediately for acute shortness of breath, inability to lie flat, or marked respiratory distress — may indicate acute respiratory failure requiring emergent ventilatory support",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Report new shortness of breath (especially lying down), morning headaches, or excessive daytime sleepiness — may indicate respiratory muscle deterioration needing ventilation support",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Report palpitations, dizziness, or fainting episodes — may indicate cardiac conduction disease or cardiomyopathy requiring urgent evaluation",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Report worsening swallowing difficulty or choking episodes (OPMD patients) — aspiration risk assessment needed",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Report dark or cola-colored urine after exercise or illness — may indicate rhabdomyolysis requiring IV hydration",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Maintain regular follow-up with cardiology and pulmonology even if asymptomatic — cardiac and respiratory complications may be silent",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Inform ALL healthcare providers (surgeons, anesthesiologists, dentists) of muscular dystrophy diagnosis before any procedure requiring sedation or anesthesia",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Regular low-impact aerobic exercise (swimming, recumbent cycling) as tolerated to maintain cardiovascular fitness; avoid eccentric/high-resistance exercise which may worsen muscle damage",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Stretching program to prevent and manage contractures; daily range-of-motion exercises for all joints",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Maintain healthy weight: obesity worsens mobility and respiratory function; underweight/sarcopenia worsens weakness",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Fall prevention measures: grab bars, non-slip surfaces, assistive devices; home safety evaluation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Annual influenza and pneumococcal vaccination; COVID-19 vaccination per guidelines to prevent respiratory infections",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Aspiration precautions for OPMD patients: upright positioning during meals; thickened liquids as recommended by speech therapy",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Inflammatory myopathy (DM/PM/IBM)",
      "features": "Subacute onset; may have skin rash (DM); elevated CK; responds to immunosuppression (except IBM); autoantibodies present",
      "tests": "Myositis antibody panel; muscle biopsy (inflammatory infiltrate); MRI (edema vs fatty infiltration); response to steroids"
    },
    {
      "diagnosis": "Myotonic dystrophy",
      "features": "Myotonia (delayed relaxation); distal weakness; cataracts; cardiac conduction defects; characteristic facies; DMPK/CNBP genetic testing",
      "tests": "Genetic testing (CTG repeat in DM1; CCTG in DM2); EMG (myotonic discharges); clinical exam (grip myotonia)"
    },
    {
      "diagnosis": "Spinal muscular atrophy (adult-onset, SMA type 3/4)",
      "features": "Proximal weakness without CK elevation (or mild); lower motor neuron pattern on EMG; SMN1 deletion",
      "tests": "SMN1 gene deletion testing; EMG (neurogenic not myopathic); CK normal/mildly elevated"
    },
    {
      "diagnosis": "Metabolic myopathy (Pompe, McArdle, CPT2 deficiency)",
      "features": "Exercise intolerance; episodic rhabdomyolysis; specific enzyme deficiencies",
      "tests": "GAA enzyme activity (Pompe); muscle biopsy (glycogen/lipid storage); ischemic forearm test; genetic testing"
    },
    {
      "diagnosis": "Myasthenia gravis",
      "features": "Fatigable weakness; fluctuating; ptosis and diplopia common; no CK elevation",
      "tests": "AChR or MuSK antibodies; RNS/SFEMG; edrophonium test; normal CK"
    },
    {
      "diagnosis": "Hypothyroid myopathy",
      "features": "Proximal weakness with elevated CK; hypothyroid symptoms; reversible with treatment",
      "tests": "TSH (elevated); Free T4 (low); symptoms resolve with thyroid replacement"
    },
    {
      "diagnosis": "Statin myopathy",
      "features": "Proximal weakness with CK elevation in setting of statin use; anti-HMGCR antibodies in immune-mediated necrotizing myopathy",
      "tests": "Statin history; anti-HMGCR antibodies; improvement with statin discontinuation (unless immune-mediated)"
    }
  ],
  "evidence": [
    {
      "recommendation": "Cardiac screening recommended for all muscular dystrophy patients",
      "evidenceLevel": "Class I, Level B",
      "source": "[Groh WJ et al. Heart Rhythm 2008](https://pubmed.ncbi.nlm.nih.gov/18065285/)"
    },
    {
      "recommendation": "LMNA mutation carriers: prophylactic ICD reduces sudden cardiac death risk",
      "evidenceLevel": "Class IIa, Level B",
      "source": "[Meune C et al. J Am Coll Cardiol 2006](https://pubmed.ncbi.nlm.nih.gov/17236468/)"
    },
    {
      "recommendation": "ACE inhibitors delay cardiomyopathy progression in Becker MD",
      "evidenceLevel": "Class IIa, Level B",
      "source": "[Duboc D et al. J Am Coll Cardiol 2005](https://pubmed.ncbi.nlm.nih.gov/15766818/)"
    },
    {
      "recommendation": "NIV improves survival in neuromuscular respiratory failure",
      "evidenceLevel": "Class I, Level B",
      "source": "[Simonds AK. Eur Respir J 2006](https://pubmed.ncbi.nlm.nih.gov/16585081/)"
    },
    {
      "recommendation": "Avoid succinylcholine in all muscular dystrophies (hyperkalemic arrest risk)",
      "evidenceLevel": "Class I, Level C",
      "source": "[Hayes J et al. Br J Anaesth 2008](https://pubmed.ncbi.nlm.nih.gov/18344556/)"
    },
    {
      "recommendation": "FSHD genetic diagnosis: D4Z4 contraction on 4qA allele",
      "evidenceLevel": "Class I, Level A",
      "source": "[Lemmers RJLF et al. Science 2010](https://pubmed.ncbi.nlm.nih.gov/20724583/)"
    },
    {
      "recommendation": "LGMD classification update (2018)",
      "evidenceLevel": "Consensus",
      "source": "[Straub V et al. Neuromuscul Disord 2018](https://pubmed.ncbi.nlm.nih.gov/30055862/)"
    },
    {
      "recommendation": "Cricopharyngeal myotomy improves swallowing in OPMD",
      "evidenceLevel": "Class IIa, Level B",
      "source": "[Coiffier L et al. Neuromuscul Disord 2006](https://pubmed.ncbi.nlm.nih.gov/18632466/)"
    }
  ],
  "monitoring": [
    {
      "item": "Echocardiogram (EF, LV dimensions)",
      "frequency": "Annually; q6mo if cardiomyopathy present",
      "action": "Initiate/optimize ACE inhibitor and beta-blocker; cardiology referral; cardiac MRI",
      "ED": "URGENT",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "URGENT"
    },
    {
      "item": "ECG / Holter monitor",
      "frequency": "Annually; q6mo for EDMD/LMNA carriers",
      "action": "EP evaluation; ICD/pacemaker consideration for LMNA; antiarrhythmics",
      "ED": "STAT",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "STAT"
    },
    {
      "item": "Pulmonary function tests (FVC, MIP, MEP)",
      "frequency": "Q6-12 months",
      "action": "Initiate NIV if FVC <50% or symptomatic; pulmonology referral",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Overnight oximetry",
      "frequency": "Annually if FVC <80%; or if symptoms of nocturnal hypoventilation",
      "action": "Initiate nocturnal BiPAP; formal sleep study",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "CK level",
      "frequency": "Baseline; then as clinically indicated",
      "action": "Hydration; renal monitoring if markedly elevated",
      "ED": "STAT",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "STAT"
    },
    {
      "item": "Swallowing assessment (OPMD)",
      "frequency": "Q6-12 months",
      "action": "Diet modification; speech therapy; consider cricopharyngeal myotomy",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Functional mobility assessment (timed up-and-go, 6MWT)",
      "frequency": "Q6-12 months",
      "action": "PT reassessment; assistive device prescription; wheelchair evaluation if needed",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Bone density (DEXA)",
      "frequency": "Q2 years; annually if on steroids",
      "action": "Calcium, vitamin D supplementation; bisphosphonate if osteoporosis",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-"
    }
  ],
  "disposition": [
    {
      "disposition": "Discharge from ED",
      "criteria": "Stable respiratory function; no acute cardiac arrhythmia; no rhabdomyolysis; outpatient neuromuscular follow-up arranged"
    },
    {
      "disposition": "Admit to floor",
      "criteria": "Acute respiratory decompensation requiring NIV; rhabdomyolysis with CK >10x ULN; new cardiac arrhythmia; aspiration pneumonia; new diagnosis requiring expedited workup"
    },
    {
      "disposition": "Admit to ICU",
      "criteria": "Respiratory failure requiring intubation or continuous NIV; cardiac arrhythmia requiring monitoring/intervention; severe rhabdomyolysis with AKI; perioperative monitoring"
    },
    {
      "disposition": "Outpatient follow-up (neuromuscular)",
      "criteria": "All patients: q6-12 months; more frequently if declining; genetic counseling if new diagnosis"
    },
    {
      "disposition": "Outpatient follow-up (cardiology/pulmonology)",
      "criteria": "Annually minimum for all dystrophy patients; q3-6 months if cardiomyopathy or respiratory involvement"
    }
  ]
}